Wire Stories
DESTINY-Lung02 Phase 2 Trial of ENHERTU� Initiated in Patients with HER2 Mutated Metastatic Non-Small Cell Lung Cancer
TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the first patient was...